Ublituximab in Autoantibody Positive Immune Mediated Necrotizing Myopathy
for Autoimmune Disorders
8 locations incl. Birmingham
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Sex: All·Age: 18+
Code: NCT07103746·Phase 2·Recruiting·Listed Aug 2025